Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tivantinib in 2nd-line HCC
NCT00988741Phase 2Completed
- Start
- Sep 2009
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of tivantinib in hepatocellular carcinoma (HCC). Started Sep 2009; status: completed.
02
Drugs
tivantinib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00988741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00988741.